Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Mycophenolic acid may help hair grow by activating pathways important for hair growth.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Panitumumab can cause excessive ear hair growth.

TPA is about 50 times more effective at promoting tumors than MZ.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

The solid microneedle booster improves hair regrowth and follicle enrichment when used with minoxidil.

AMH is a reliable marker for diagnosing PCOS.

Baricitinib improved hair loss and arthritis in a lupus patient.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

MPA increases cancer spread by boosting Eph A2 activity.

Unani treatment improved symptoms of PMOS in a young woman.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

A new method accurately detects bisphenols and parabens in human hair.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

The new treatment was safe and may effectively treat male pattern hair loss.

Looser dietary restrictions can improve growth and reduce illness in methylmalonic acidemia patients.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Bimekizumab effectively treated a man's chronic beard hair loss.

Abatacept may help some people with alopecia areata regrow hair.